3DPOD Episode 213: 3D Printed Personalized Medicine with Wei Jiang, Craft Health
Wei Jiang founded medicine 3D printing startup Craft Health as a Pharmacy student. I love it when practitioners and people from other backgrounds establish 3D printing companies. It often leads to user-driven companies that cater well to those trying to use additive manufacturing. In this episode of the 3DPOD, we follow Craft Health’s journey from inception to funding and the release of the firm’s 3D printer for pharmaceuticals. We discuss release kinetics, approvals, drug delivery, compounding pharmacies, dosage forms, polypills, delayed release, nutrition, dementia care, and much more. 3D printing for pharmaceuticals has significant potential, and not enough people are paying attention.
Podcast: Play in new window | Download
Podcast (podcast-audio): Play in new window | Download
Subscribe to Our Email Newsletter
Stay up-to-date on all the latest news from the 3D printing industry and receive information and offers from third party vendors.
You May Also Like
Investing in Tooling Innovation is Key to Reshoring Success
Outsourcing and retirement have dramatically shrunk the manufacturing workforce in the U.S., creating a challenge to efforts at reshoring production production. Pictured here is a toolmaker assembling an injection mold,...
3D Printing Webinar and Event Roundup: January 19, 2025
We have a couple of in-person events in Las Vegas to tell you about this week, plus a few webinars, including one about 3D printing for dental restorations. Read on...
Additive Industries Talks 3D Printing for RF Components, Automotive, & More
Dutch company Additive Industries, which first unveiled its flagship MetalFab industrial 3D printing system in 2015 and officially launched it in 2017, was very busy last year. At Formnext 2023,...
Additive Manufacturing’s Opportunity: The Agile Solution to the US Manufacturing Crunch
The US manufacturing sector is bracing for what could be a perfect storm of supply shortages and surging demand. This ‘storm’, driven by reshoring efforts, potential tariffs, and ongoing manufacturing...
